MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Karolinska University Hospital
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska University Hospital (5)
2018
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation
Leukemia, Vol. 32, Núm. 5, pp. 1070-1080
2010
-
International network of cancer genome projects
Nature, Vol. 464, Núm. 7291, pp. 993-998
2007
1999
-
Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia
Leukemia, Vol. 13, Núm. 1, pp. 110-118
-
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
Leukemia